CV Sciences, Inc. (PNK:CVSI) Q4 2024 Earnings Call Transcript March 27, 2025 Operator: Greetings. Welcome to the CV Sciences Fourth Quarter and Year End 2024 Financial Results Conference Call.

Greetings and welcome to the CV Sciences fourth quarter and year end, 2024 financial results conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer ...

Greetings and welcome to the CV Sciences fourth quarter and year end, 2024 financial results conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer ...

CV Sciences Inc (CVSI) achieved a gross margin improvement from 44.3% in 2023 to 45.6% in 2024, indicating better cost management. The company successfully launched the +PlusHLTH line of ...

CV Sciences is focused on driving profitability through product innovation, cost optimization, and strategic acquisitions. The launch of new product lines, including cannabinoid-free supplements ...

Greetings and welcome to the CV Sciences’ Fourth Quarter and Year-End 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and ...

CV Sciences Inc. (CVSI) reported its financial results for the fourth quarter and full year of 2024, showing steady revenue figures and strategic operational shifts. The company’s revenue for ...

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness ...

CV Sciences, Inc. (PNK:CVSI) Q4 2024 Earnings Call Transcript 27.03. CV Sciences, Inc. - 10-K, Annual Report 27.03. CV Sciences targets profitability with new product lines and M&A strategy in ...